Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Peritoneal Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01100372
What this trial is testing

Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Medical University Innsbruck 154
Early research (Phase 1)Study completedNCT05858736
What this trial is testing

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

Who this might be right for
MelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more
OncoC4, Inc. 18
Not applicableStudy completedNCT00293293
What this trial is testing

Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine

Who this might be right for
Ovarian CancerPeritoneal Primary CancerFallopian Tube Cancer
Masonic Cancer Center, University of Minnesota 43
Testing effectiveness (Phase 2)Study completedNCT03333915
What this trial is testing

Study of the Efficacy, Safety and Pharmacokinetics of Pamiparib (BGB-290) in Participants With Advanced Solid Tumors

Who this might be right for
Advanced High-grade Ovarian CancerTriple Negative Breast Cancer
BeiGene 128
Post-approval studies (Phase 4)Study completedNCT01932125
What this trial is testing

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms
Hoffmann-La Roche 100
Early research (Phase 1)Study completedNCT02121990
What this trial is testing

Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
Memorial Sloan Kettering Cancer Center 17
Testing effectiveness (Phase 2)Ended earlyNCT00799110
What this trial is testing

Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod

Who this might be right for
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
Beth Israel Deaconess Medical Center 15
Testing effectiveness (Phase 2)UnknownNCT00003560
What this trial is testing

Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+1 more
Herbert Irving Comprehensive Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT00041080
What this trial is testing

Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerPrimary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer+2 more
National Cancer Institute (NCI) 139
Not applicableEnded earlyNCT00287482
What this trial is testing

Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer.

Who this might be right for
Ovarian CancerBreast Cancer
Women and Infants Hospital of Rhode Island 20
Testing effectiveness (Phase 2)Ended earlyNCT00748527
What this trial is testing

Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Cancer Research UK 134
Large-scale testing (Phase 3)Study completedNCT02891824
What this trial is testing

ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 614
Testing effectiveness (Phase 2)Ended earlyNCT00053833
What this trial is testing

S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
SWOG Cancer Research Network 2
Early research (Phase 1)Active Not RecruitingNCT05691504
What this trial is testing

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaMetastatic Fallopian Tube Carcinoma+8 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03355976
What this trial is testing

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+2 more
Brown University 46
Testing effectiveness (Phase 2)Looking for participantsNCT07023484
What this trial is testing

Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
The University of Hong Kong 126
Testing effectiveness (Phase 2)Ended earlyNCT01035658
What this trial is testing

Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Carcinoma
SCRI Development Innovations, LLC 22
Not applicableStudy completedNCT05047926
What this trial is testing

Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Who this might be right for
Advanced Ovarian CarcinomaStage IIIC Fallopian Tube Cancer AJCC v8Stage IIIC Ovarian Cancer AJCC v8+4 more
Mayo Clinic 90
Testing effectiveness (Phase 2)Study completedNCT00039585
What this trial is testing

Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT01376349
What this trial is testing

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Who this might be right for
Breast CancerGynecologic Cancer
Alliance for Clinical Trials in Oncology 464
Next Page